Thiosulfuric Acid

Summary

Thiosulfuric Acid (CHEMBL1208642) is an approved small molecule (ATC V03AB06).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: V03AB06
• Clinical trials: 1
• Chemistry: 114.15 Da · H2O3S2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1208642
Name	Thiosulfuric Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	24478
ChEBI	CHEBI:29279
ATC	V03AB06
Molecular formula	H2O3S2
Molecular weight	114.15
InChIKey	DHCDFWKWKRSZHF-UHFFFAOYSA-N

SMILES: OS(=O)(=S)O

IUPAC name: sulfurothioic O-acid

Also known as: Thiosulfate, THIOSULFURIC ACID

Parent form; salt/anhydrous children: CHEMBL2096650, CHEMBL2251960, CHEMBL3753202

Patent coverage: 65,374 distinct patent families (155,829 SureChEMBL compound mentions), from 4 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 1.

Phase distribution

Phase	Trials
PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01114958	PHASE1	COMPLETED	Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).